Estimating the whole-body effective dose and health risks as well as introducing a new easy method for eye lens dosimetry in interventional cardiology procedures.

Cancer risk Dose estimation Eye lens dosimetry Interventional Cardiology Whole-body dose

Journal

MethodsX
ISSN: 2215-0161
Titre abrégé: MethodsX
Pays: Netherlands
ID NLM: 101639829

Informations de publication

Date de publication:
2020
Historique:
received: 02 08 2020
accepted: 05 10 2020
entrez: 2 11 2020
pubmed: 3 11 2020
medline: 3 11 2020
Statut: epublish

Résumé

This study aimed to introduce a new method for eye lens thermo-luminescent dosimetry and also estimate the dose associated with induced cancer risk due to the ionizing radiation exposure received by physicians and other staff cooperating in interventional cardiology (IC) procedures. The measurements were performed with six TLDs (thermoluminescent dosimeters): four TLDs for eye lens dosimetry (2 positioned on respiratory/surgical mask under the eye region as the new method; and 2 near the outside border of the eye as the common method) and two TLDs for whole-body dosimetry. Whole-body doses were used to calculate the cancer risks induced by IC procedures. The results of the new proposed method for eye lens dosimetry were similar to common TLD positioning (mean differences <5%) and mask displacement had no significant effect on eye dose measurement in our new method. Our proposed method for eye lens dosimetry is simpler and more comfortable compared to the common method and it can be used as an alternative method without using TLD holders to monitor lens dose for IC workers wearing masks during the procedure. The estimated excess cancer incidence risk induced by IC procedures was 29.58 ± 5.71 and 46.68 ± 7.77 (per 100000 individuals) for men and women, respectively.

Identifiants

pubmed: 33134097
doi: 10.1016/j.mex.2020.101097
pii: S2215-0161(20)30317-4
pmc: PMC7586141
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101097

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Radiol Prot. 2015 Sep;35(3):R17-34
pubmed: 26343787
Eur J Epidemiol. 2018 Dec;33(12):1179-1191
pubmed: 30151727
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
Health Phys. 1994 Jul;67(1):88-9
pubmed: 8200807
Ann ICRP. 2012 Feb;41(1-2):1-322
pubmed: 22925378
Radiat Prot Dosimetry. 2011 Mar;144(1-4):257-61
pubmed: 21362692
Radiology. 2008 Sep;248(3):945-53
pubmed: 18632529
Radiat Prot Dosimetry. 2012 Sep;151(3):450-5
pubmed: 22434922
Radiat Prot Dosimetry. 2008;129(1-3):333-9
pubmed: 18483007
Radiat Prot Dosimetry. 2015 Jul;165(1-4):289-93
pubmed: 25809107

Auteurs

Alireza Hatami (A)

Department of Medical Physics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Mahmoud Bagheri (M)

Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran.
Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Sina Campus, Tehran, Iran.

Farzaneh Falahati (F)

Department of Medical Physics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Amin Banaei (A)

Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Razzagh Abedi-Firouzjah (R)

Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.

Hamed Zamani (H)

Department of Medical Physics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Mohammad Kiapour (M)

Department of Medical Physics Radiobiology and Radiation Protection, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

Farideh Momeni (F)

Medical Physics and Medical Engineering Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Classifications MeSH